Food Standards Australia New Zealand (FSANZ) has approved Arla Foods Ingredients’ application for the use of its milk fat globule membrane (MFGM) as a nutritive ingredient in infant formula products. Following formal acceptance by the Australia and New Zealand Food Ministers Meeting, the approval is now effective, and the company has been granted exclusive commercialization rights.

Alrla Foods Ingredients’ Lacprodan MFGM-10 will be the only MFGM ingredient approved for use in products for infants Australia for a minimum of 15 months. Lacprodan MFGM-10 is also the company’s first early life nutrition product to be approved by Australian authorities.

The decision only applies to Australia, where Lacprodan MFGM-10 can now be labeled as “Milk fat globule membrane-enriched whey protein concentrate,” but not New Zealand, which recently opted out of the Australia-New Zealand joint infant formula products standard.

MFGM occurs naturally in human milk and contains phospholipids, sphingolipids, and gangliosides. Lacprodan MFGM-10 is the first bovine MFGM ingredient for the global formula market, and has clinical documentation for infant nutrition and immune health, per Arla Foods Ingredients.

Earlier in 2025, the EU confirmed that Lacprodan MFGM-10 is not considered a novel food, allowing its use in products for infants and adults.